648 related articles for article (PubMed ID: 12168088)
21. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
[TBL] [Abstract][Full Text] [Related]
22. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
23. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer.
Kikuno N; Yoshino T; Urakami S; Shigeno K; Kishi H; Hata K; Shiina H; Igawa M
Anticancer Res; 2003; 23(2B):1305-12. PubMed ID: 12820387
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
Büchler P; Reber HA; Büchler M; Shrinkante S; Büchler MW; Friess H; Semenza GL; Hines OJ
Pancreas; 2003 Jan; 26(1):56-64. PubMed ID: 12499918
[TBL] [Abstract][Full Text] [Related]
26. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
[TBL] [Abstract][Full Text] [Related]
27. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
28. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
30. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
[TBL] [Abstract][Full Text] [Related]
31. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
33. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
[TBL] [Abstract][Full Text] [Related]
34. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes.
Huang YQ; Li JJ; Hu L; Lee M; Karpatkin S
Thromb Haemost; 2001 Oct; 86(4):1094-8. PubMed ID: 11686329
[TBL] [Abstract][Full Text] [Related]
35. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
37. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
38. [Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma].
Altomare DF; Rotelli MT; Memeo V; Martinelli E; Guglielmi A; DeFazio M; D'Elia G; Pentimone A; Colucci M; Semeraro N
Tumori; 2003; 89(4 Suppl):5-6. PubMed ID: 12903530
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
